👉 Visit https://oncoassist.com/ to streamline patient care with cutting-edge tools, treatment protocols, and calculators!

🔬In this episode of Oncology Spotlight, Dr. Shaqil Kassam shares a powerful perspective from the front lines of community oncology in Canada.

From drug access delays in publicly funded systems to the real-world challenges of administering bispecific therapies outside academic centers, this conversation dives into the complexity of modern oncology.

We also explore:

• Community vs academic oncology – what truly differs?

• The global equity gap in cancer care

• How AI is already transforming clinic workflows and pathology

• The real challenges behind sequencing new therapies

• Why equitable access remains the biggest global barrier
  

This is a must-watch for oncologists, trainees, and healthcare leaders navigating rapid innovation in constrained systems.

📌 CHAPTERS & TIMESTAMPS

🏥 00:00 – The Biggest Issue: Drug Access in Public Healthcare

🎙️ 00:36 – Introduction & Guest Overview

👨‍⚕️ 01:07 – Dr. Kassam’s Journey to Medical Oncology

🌍 03:29 – Community vs Academic Oncology Explained

📊 06:33 – Are 80% of Patients Treated in Community Settings?

🤝 08:00 – Collaboration Between Community & Academic Oncologists

🎧 08:44 – The MedOncNow Podcast: Why It Started

💊 10:49 – Practical Implementation of New Cancer Drugs

🌎 13:07 – The Future of Oncology in Canada

⚖️ 16:05 – Equity: Canada’s Strength & Global Weakness

🌍 17:05 – Barriers to Global Cancer Care

🧠 21:40 – AI in Oncology: From Dictation to Digital Pathology

🎓 25:14 – Advice for Future Oncologists

📢 JOIN THE CONVERSATION! ❓Drop your thoughts in the comments below!📲 Oncology at your fingertips.

Download the ONCOassist app:

📥 iOS: https://apple.co/4iuMxfS

📥 Android: https://bit.ly/oncoassistonandroid

📥Webapp: https://bit.ly/ONCOassistOnWeb

🚀 SUBSCRIBE to the ONCOassist Youtube Channel for more expert insights!🔔 Turn on notifications so you never miss an episode.

📌 FOLLOW US FOR UPDATES:

📍 LinkedIn: https://bit.ly/oncoassistlinkedin

📍 Twitter/X: https://bit.ly/oncoassisttwitter

🔬In this episode, Dr. Shreyas Kalantri shares his journey from medical training in India to academic oncology in the United States, and reflects on what truly defines progress in cancer care.

The conversation dives deep into quality of life as a critical endpoint, disparities in immunotherapy access, the role of academic research, global oncology collaboration, and how AI can reshape oncology workflows. Dr. Kalantri also discusses his work with the HemOnc Fellows Network and ASCO’s Training & Early Career Advisory Group, highlighting the importance of mentorship and democratizing oncology education worldwide.

This episode is essential listening for oncologists, trainees, and healthcare professionals navigating the rapidly evolving oncology landscape.

🔹 Key Topics Covered

• Why quality of life should contextualize survival outcomes

• Gaps in quality-of-life reporting in clinical trials

• The HemOnc Fellows Network

• Academic oncology vs community practice

• Global oncology and trainee mentorship initiatives

• AI, digital tools, and the future of oncology workflows

• Advice for trainees considering a career in oncology

🎬A must-watch episode for oncologists, trainees, and healthcare leaders shaping the future of cancer care.

Connect with Shreyas Kalantri here: https://www.linkedin.com/in/shreyaskalantrimd/

📲 Oncology at your fingertips.

Download the ONCOassist app:

📥 iOS: https://apple.co/4iuMxfS

📥 Android: https://bit.ly/oncoassistonandroid

📥Webapp: https://bit.ly/ONCOassistOnWeb

📌 FOLLOW US FOR UPDATES: 📍 LinkedIn: https://bit.ly/oncoassistlinkedin

📍 Twitter/X: https://bit.ly/oncoassisttwitter

👉 Visit https://oncoassist.com/ to streamline patient care with cutting-edge tools, guidelines, and calculators!

🔬In this episode of Oncology Spotlight, we sit down with Katy Winckworth-Prejsnar, Director of the Global Program at NCCN (National Comprehensive Cancer Network). Katy offers a behind-the-scenes look at how NCCN’s guidelines are being adapted and implemented globally especially in low- and middle-income countries.

She speaks on equity in access to cancer care, the challenges and opportunities in global implementation of NCCN Guidelines, and her unique path into oncology from a background in cancer genetics, community outreach, and health equity.

🧭 What you’ll learn in this episode:

• The mission of NCCN’s Global Program and its real-world impact

• How local adaptation of guidelines empowers low-resource settings

• Challenges in global cancer guideline dissemination

• Why policy, education, and advocacy are just as important as treatment

• Katy's powerful career journey into global oncology
  

🎧 Listen now and get inspired by how strategic collaboration and culturally informed adaptations are shaping the future of oncology around the world.

Connect with Katy Winckworth-Prejsnar here: https://www.linkedin.com/in/katywinckworthprejsnar/

📲 Oncology at your fingertips.

Download the ONCOassist app:

📥 iOS: https://apple.co/4iuMxfS

📥 Android: https://bit.ly/oncoassistonandroid

📥Webapp: https://bit.ly/ONCOassistOnWeb

🚀 SUBSCRIBE to the ONCOassist Podcast for more expert insights!

🔔 Turn on notifications so you never miss an episode.

📌 FOLLOW US FOR UPDATES:

📍 LinkedIn: https://bit.ly/oncoassistlinkedin

📍 Twitter/X: https://bit.ly/oncoassisttwitter